000 01425 a2200433 4500
005 20250514211220.0
264 0 _c20041207
008 200412s 0 0 eng d
022 _a0033-2917
024 7 _a10.1017/s0033291703001715
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMarcelis, M
245 0 0 _aAbnormal response to metabolic stress in schizophrenia: marker of vulnerability or acquired sensitization?
_h[electronic resource]
260 _bPsychological medicine
_cAug 2004
300 _a1103-11 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAntimetabolites
650 0 4 _aBlood Glucose
650 0 4 _aCase-Control Studies
650 0 4 _aDeoxyglucose
650 0 4 _aFemale
650 0 4 _aGenetic Predisposition to Disease
650 0 4 _aHomovanillic Acid
_xmetabolism
650 0 4 _aHumans
650 0 4 _aHydrocortisone
_xblood
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPedigree
650 0 4 _aPlacebos
650 0 4 _aSchizophrenia
_xgenetics
700 1 _aCavalier, E
700 1 _aGielen, J
700 1 _aDelespaul, P
700 1 _aVan Os, J
773 0 _tPsychological medicine
_gvol. 34
_gno. 6
_gp. 1103-11
856 4 0 _uhttps://doi.org/10.1017/s0033291703001715
_zAvailable from publisher's website
999 _c15240751
_d15240751